195 related articles for article (PubMed ID: 24130071)
1. Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma.
Nadal E; Chen G; Gallegos M; Lin L; Ferrer-Torres D; Truini A; Wang Z; Lin J; Reddy RM; Llatjos R; Escobar I; Moya J; Chang AC; Cardenal F; Capellà G; Beer DG
Clin Cancer Res; 2013 Dec; 19(24):6842-52. PubMed ID: 24130071
[TBL] [Abstract][Full Text] [Related]
2. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
[TBL] [Abstract][Full Text] [Related]
3. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.
Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL
Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J
Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.
Hiroki E; Suzuki F; Akahira J; Nagase S; Ito K; Sugawara J; Miki Y; Suzuki T; Sasano H; Yaegashi N
Int J Cancer; 2012 Aug; 131(4):E395-404. PubMed ID: 22052540
[TBL] [Abstract][Full Text] [Related]
9. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
[TBL] [Abstract][Full Text] [Related]
10. miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma.
Sato T; Shiba-Ishii A; Kim Y; Dai T; Husni RE; Hong J; Kano J; Sakashita S; Iijima T; Noguchi M
Cancer Sci; 2017 Mar; 108(3):536-542. PubMed ID: 28012229
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
[TBL] [Abstract][Full Text] [Related]
12. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
[TBL] [Abstract][Full Text] [Related]
13. ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
Tessema M; Yingling CM; Picchi MA; Wu G; Ryba T; Lin Y; Bungum AO; Edell ES; Spira A; Belinsky SA
Cancer Lett; 2017 Dec; 410():191-200. PubMed ID: 28965852
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.
Supic G; Stefik D; Ivkovic N; Sami A; Zeljic K; Jovic S; Kozomara R; Vojvodic D; Stosic S
Sci Rep; 2022 Jan; 12(1):1296. PubMed ID: 35079080
[TBL] [Abstract][Full Text] [Related]
15. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
[TBL] [Abstract][Full Text] [Related]
16. Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
Kim YH; Lee WK; Lee EB; Son JW; Kim DS; Park JY
Clin Lung Cancer; 2017 Jan; 18(1):e13-e20. PubMed ID: 27444357
[TBL] [Abstract][Full Text] [Related]
17. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
[TBL] [Abstract][Full Text] [Related]
18. The Methylation of the p53 Targets the Genes
Voropaeva EN; Pospelova TI; Orlov YL; Churkina MI; Berezina OV; Gurazheva AA; Ageeva TA; Seregina OB; Maksimov VN
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011313
[TBL] [Abstract][Full Text] [Related]
19. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
[TBL] [Abstract][Full Text] [Related]
20. Increased S100A15 expression and decreased DNA methylation of its gene promoter are involved in high metastasis potential and poor outcome of lung adenocarcinoma.
Chen YC; Lin MC; Hsiao CC; Zheng YX; Chen KD; Sung MT; Chen CJ; Wang TY; Lin YY; Chang HC; Chen YM; Chang JC
Oncotarget; 2017 Jul; 8(28):45710-45724. PubMed ID: 28498804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
